mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.003 |